V010-5230 Screening compound: N-[2-(3-cyclopentylpropanamido)cyclohexyl]-2-{[4-(propan-2-yl)phenoxy]methyl}-1,3-thiazole-4-carboxamide

V010-5230 Screening compound: N-[2-(3-cyclopentylpropanamido)cyclohexyl]-2-{[4-(propan-2-yl)phenoxy]methyl}-1,3-thiazole-4-carboxamide
V010-5230 Screening compound: N-[2-(3-cyclopentylpropanamido)cyclohexyl]-2-{[4-(propan-2-yl)phenoxy]methyl}-1,3-thiazole-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V010-5230
N-[2-(3-cyclopentylpropanamido)cyclohexyl]-2-{[4-(propan-2-yl)phenoxy]methyl}-1,3-thiazole-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V010-5230

Molecular Formula

C28H39N3O3S (C28 H39 N3 O3 S)

Compound Name

N-[2-(3-cyclopentylpropanamido)cyclohexyl]-2-{[4-(propan-2-yl)phenoxy]methyl}-1,3-thiazole-4-carboxamide

IUPAC name

N-[2-(3-cyclopentylpropanamido)cyclohexyl]-2-{[4-(propan-2-yl)phenoxy]methyl}-13-thiazole-4-carboxamide

SMILES

CC(C)c(cc1)ccc1OCc1nc(C(NC(CCCC2)C2NC(CCC2CCCC2)=O)=O)cs1

InChI

InChI=1S/C28H39N3O3S/c1-19(2)21-12-14-22(15-13-21)34-17-27-30-25(18-35-27)28(33)31-24-10-6-5-9-23(24)29-26(32)16-11-20-7-3-4-8-20/h12-15,18-20,23-24H,3-11,16-17H2,1-2H3,(H,29,32)(H,31,33)

InChI Key

JSJGBHCLKZIRIK-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19968176

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

497.7

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

6.271

Distribution Coefficient, logD

6.271

Water Solubility, LogSw

-5.46

Polar Surface Area

67.177

Acid Dissociation Constant (pKa)

15.11

Base Dissociation Constant (pKb)

-0.16

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

60.70

V010-5230 in Drug Discovery

Included in Screening Libraries

3CLpro Library (4801 compounds)

ACE2 Library (3043 compounds)

CORONAVIRUS Library (20774 compounds)

GABA Library (7115 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Eye
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • GPCR
  • Ion Channels
  • Phosphatases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V010-5230 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V010-5230?
Check Price and Availability of V010-5230, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V010-5230 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V010-5230
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V010-5230
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V010-5230 available by request